Compare · SYRA vs VRSK
SYRA vs VRSK
Side-by-side comparison of Syra Health Corp. (SYRA) and Verisk Analytics Inc. (VRSK): market cap, price performance, sector, and recent activity on the wire.
Summary
- SYRA operates in Consumer Discretionary, while VRSK operates in Industrials - the two are in different parts of the market.
- VRSK carries a market cap of $23.17B.
- Over the past year, SYRA is up 0.0% and VRSK is down 32.2% - SYRA leads by 32.2 points.
- VRSK has been more active in the news (11 items in the past 4 weeks vs 3 for SYRA).
- VRSK has more recent analyst coverage (25 ratings vs 0 for SYRA).
- Company
- Syra Health Corp.
- Verisk Analytics Inc.
- Price
- $0.18+42.31%
- $178.02+1.38%
- Market cap
- -
- $23.17B
- 1M return
- +0.00%
- -1.74%
- 1Y return
- +0.00%
- -32.24%
- Industry
- Diversified Commercial Services
- Diversified Commercial Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2023
- 2009
- News (4w)
- 3
- 11
- Recent ratings
- 0
- 25
Verisk Analytics Inc.
Verisk Analytics, Inc. provides data analytics solutions in the United States and internationally. It provides predictive analytics and decision support solutions to customers in rating, underwriting, claims, catastrophe and weather risk, global risk analytics, natural resources intelligence, economic forecasting, commercial banking and finance, and various other fields. The company operates through three segments: Insurance, Energy and Specialized Markets, and Financial Services. The Insurance segment focuses on the prediction of loss, selection and pricing of risk, and compliance with their reporting requirements for property and casualty customers. It also develops machine learned and artificially intelligent models to forecast scenarios and produce standard and customized analytics that help its customers to manage their businesses, including detecting fraud before and after a loss event, and quantifying losses. The Energy and Specialized Markets segment provides data analytics for the natural resources value chain, including energy, chemicals, metals, mining, power, and renewables sectors; research and consulting services focusing on exploration strategies and screening, asset development and acquisition, commodity markets, and corporate analysis; and consultancy services in the areas of business environment, business improvement, business strategies, commercial advisory, and transaction support, as well as analysis and advice on assets, companies, governments, and markets. The Financial Services segment offers benchmarking, decisioning algorithms, business intelligence, and customized analytic services to financial institutions, payment networks and processors, alternative lenders, regulators, and merchants. The company was founded in 1971 and is headquartered in Jersey City, New Jersey.
Latest SYRA
- Syra Health, in Partnership with HealthSync, Selected for CMS ACCESS Model, Advancing Long-Term Growth Strategy
- SEC Form 4 filed by COO and CFO Prasad Priya
- Syra Health, Wake County Public Health Expand Wellness Partnership
- SEC Form 4 filed by CEO Alexander Gregory R.
- SEC Form S-8 filed by Syra Health Corp.
- SEC Form 10-Q filed by Syra Health Corp.
- Syra Health Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Syra Health Achieves 23% Revenue Growth, Improves Gross Margin to 44.5% in Second Consecutive Profitable Quarter
- Syra Health To Announce Second Quarter 2026 Financial Results
- Syra Health Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
Latest VRSK
- SEC Form 8-K filed by Verisk Analytics Inc.
- Unmasking Fraud: Verisk Releases Fraud Discovery, connecting intelligence, analytics and investigations in one powerful fraud platform
- Verisk CargoNet Reports Persistent Labor Day Cargo Theft Exposure Across U.S. Freight Networks
- Amid AI Boom, Verisk Launches New View of U.S. Data Center Exposure, Helping Insurers Assess Growing Concentrations of Risk
- Chief Executive Officer Shavel Lee exercised 3,535 shares at a strike of $104.00 and sold $683,775 worth of shares (3,535 units at $193.43) as part of a pre-agreed trading plan (SEC Form 4)
- U.S. P&C Insurers Post Strong Underwriting Gains Through First Half of 2026; Line-Specific and Geographic Challenges Persist
- Accuserve Solutions Appoints Maroun S. Mourad as an Independent Board Member
- Europe's Insured Losses Are Climbing as Catastrophes, Inflation and Construction Costs Combine, Verisk Finds
- Global Insured Catastrophe Losses Now Expected to Average $171 Billion Annually, Verisk Finds
- SEC Form 8-K filed by Verisk Analytics Inc.